Filing Details

Accession Number:
0001103021-19-000039
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-19 16:39:12
Reporting Period:
2019-11-15
Accepted Time:
2019-11-19 16:39:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1103021 Biodelivery Sciences International Inc BDSI Pharmaceutical Preparations (2834) 352089858
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1757833 James Vollins C/O Biodelivery Sciences Intl, Inc.
4131 Parklake Ave. Suite 225
Raleigh NC 27612
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-15 29,825 $3.46 29,825 No 4 M Direct
Common Stock Disposition 2019-11-15 29,825 $6.09 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (right to buy) Disposition 2019-11-15 29,825 $0.00 29,825 $3.46
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
59,651 2028-11-05 No 4 M Direct
Footnotes
  1. The stock options were issued to the Reporting Person on November 5, 2018, pursuant to a grant under the Company's 2011 Equity Incentive Plan, as amended. The award is subject to time-based vesting and a third has vested on November 5, 2019. The remaining options vest in equal portions on:(i) November 5, 2020; and (ii) November 5, 2021.